Wild rodents as a model to discover genes and pathways underlying natural variation in infectious disease susceptibility

Parasite Immunology

Volumn 35, Issue 11, 2013, Pages 386-395

  Turner, A K ^a   Paterson, S ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Cytokines; Evolution; Immunogenetics; Infectious disease susceptibility; Natural populations; Pathogen resistance; Wild rodents

Indexed keywords

CYTOKINE; MESSENGER RNA; TOLL LIKE RECEPTOR; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR;

CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; EVOLUTION; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HOST PATHOGEN INTERACTION; HOST RESISTANCE; IMMUNOGENETICS; INFECTION; INFECTION RESISTANCE; INFLAMMATION; NATURAL POPULATION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PUUMALA VIRUS; REVIEW; RODENT; WILD ANIMAL; ANIMAL; ANIMAL MODEL; DISEASE RESISTANCE; GENETIC VARIATION; GENETICS; HUMAN; IMMUNOLOGY; PROCEDURES;

ANIMALS; ANIMALS, WILD; CYTOKINES; DISEASE RESISTANCE; DISEASE SUSCEPTIBILITY; GENETIC VARIATION; HUMANS; IMMUNOGENETICS; INFECTION; MODELS, ANIMAL;

EID: 84885412057     PISSN: 01419838     EISSN: 13653024     Source Type: Journal    
DOI: 10.1111/pim.12036     Document Type: Review

References (83)

1. Hill AVS. Evolution, revolution and heresy in the genetics of infectious disease susceptibility. Philos Trans R Soc Lond B Biol Sci 2012; 367: 840-849.
2. Beckers J, Wurst W & De Angelis MH. Towards better mouse models: enhanced genotypes, systemic phenotyping and envirotype modelling. Nat Rev Genet 2009; 10: 371-380.
3. Waterston RH, Lindblad-Toh K, Birney E, et al. Initial sequencing and comparative analysis of the mouse genome. Nature 2002; 420: 520-562.
4. Nguyen D & Xu T. The expanding role of mouse genetics for understanding human biology and disease. Dis Model Mech 2008; 1: 56-66.
5. Tecott LH. The genes and brains of mice and men. Am J Psychiatry 2003; 160: 646-656.
6. Griffith JW, O'Connor C, Bernard K, Town T, Goldstein DR & Bucala R. Toll-like receptor modulation of murine cerebral malaria is dependent on the genetic background of the host. J Infect Dis 2007; 196: 1553-1564.
7. Srivastava B, Błazejewska P, Hessmann M, et al. Host genetic background strongly influences the response to influenza a virus infections. PLoS ONE 2009; 4: e4857.
8. Geurts N, Martens E, Verhenne S, et al. Insufficiently defined genetic background confounds phenotypes in transgenic studies as exemplified by malaria infection in Tlr9 knockout mice. PLoS ONE 2011; 6: e27131.
9. Dalziel AC, Rogers SM & Schulte PM. Linking genotypes to phenotypes and fitness: how mechanistic biology can inform molecular ecology. Mol Ecol 2009; 18: 4997-5017.
10. Telfer S, Lambin X, Birtles R, et al. Species interactions in a parasite community drive infection risk in a wildlife population. Science 2010; 330: 243-246.
11. Abolins SR, Pocock MJO, Hafalla JCR, Riley EM & Viney ME. Measures of immune function of wild mice, Mus musculus. Mol Ecol 2011; 20: 881-892.
12. Hartl DL. Genetic management of outbred laboratory rodent populations. 2001; Available from: http://www.criver.com/sitecollectiondocuments/rm_gt_r_genetic_management_outbred_rodent.pdf. Accessed 30th October 2012.
13. Guénet JL & Bonhomme F. Wild mice: an ever-increasing contribution to a popular mammalian model. Trends Genet 2003; 19: 24-31.
14. Kelsh RN, Székely T & Stuart S. Why should biomedical scientists care about biodiversity? Curr Biol 2011; 21: R210-R211.
15. Slate J, Santure AW, Feulner PGD, et al. Genome mapping in intensively studied wild vertebrate populations. Trends Genet 2010; 26: 275-284.
16. Gibbs RA, Weinstock GM, Metzker ML, et al. Genome sequence of the Brown Norway rat yields insights into mammalian evolution. Nature 2004; 428: 493-521.
17. Pedersen AB & Babayan SA. Wild immunology. Mol Ecol 2011; 20: 872-880.
18. Elton C, Davis DHS & Findlay GM. An epidemic among voles (Microtus agrestis) on the Scottish border in the spring of 1934. J Anim Ecol 1935; 4: 277-288.
19. Elton C, Ford EB, Baker JR & Gardner AD. The health and parasites of a wild mouse population. Proc Zool Soc Lond 1931; 1: 657-721.
20. Elton CS. Voles, Mice and Lemmings. Oxford, Clarendon Press, 1942.
21. Bailey V. Breeding, feeding, and other life habits of meadow mice (Microtus). J Agri Res 1924; 27: 523.
22. Ranson RM. The field vole (Microtus) as a laboratory animal. J Anim Ecol 1934; 3: 70-76.
23. Kalthoff D, König P, Meyer H, Beer M & Hoffmann B. Experimental cowpox virus infection in rats. Vet Microbiol 2011; 153: 382-386.
24. Schmid-Hempel P. Evolutionary Parasitology: The Integrated Study of Infections, Immunology, Ecology, and Genetics. Oxford, Oxford University Press, 2011: 12.
25. Nesse RM. Ten questions for evolutionary studies of disease vulnerability. Evol Appl 2011; 4: 264-277.
26. Nesse RM, Williams GC. Why We Get Sick. The New Science of Darwinian Medicine. Vintage Books, New York, 1994.
27. Little TJ, Allen JE, Babayan SA, Matthews KR & Colegrave N. Harnessing evolutionary biology to combat infectious disease. Nat Med 2012; 18: 217-220.
28. Williams GC & Nesse RM. The dawn of Darwinian medicine. Q Rev Biol 1991; 66: 1-22.
29. Doherty PC & Zinkernagel RM. Enhanced immunological surveillance in mice heterozygous at the H-2 gene complex. Nature 1975; 256: 50-52.
30. Bodmer WF. Evolutionary significance of the HL-A system. Nature 1972; 237: 139-145.
31. Takahata N & Nei M. Allelic genealogy under overdominant and frequency-dependent selection and polymorphism of major histocompatibility complex loci. Genetics 1990; 124: 967-978.
32. Hedrick PW. Pathogen resistance and genetic variation at MHC loci. Evolution 2002; 56: 1902-1908.
33. Turner AK, Begon M, Jackson JA, Bradley JE & Paterson S. Genetic diversity in cytokines associated with immune variation and resistance to multiple pathogens in a natural rodent population. PLoS Genet 2011; 7: e1002343.
34. Carter AJR & Nguyen AQ. Antagonistic pleiotropy as a widespread mechanism for the maintenance of polymorphic disease alleles. BMC Med Genet 2011; 12: 160.
35. Spurgin LG & Richardson DS. How pathogens drive genetic diversity: MHC, mechanisms and misunderstandings. Proc Biol Sci 2010; 277: 979-988.
36. Orlova M, Di Pietrantonio T & Schurr E. Genetics of infectious diseases: hidden etiologies and common pathways. Clin Chem Lab Med 2011; 49: 1427-1437.
37. Tschirren B, Andersson M, Scherman K, Westerdahl H & Lars R. Contrasting patterns of diversity and population differentiation at the innate immunity gene Toll-like receptor 2 (TLR2) in two sympatric rodent species. Evolution 2012; 66: 720-731.
38. Paterson S & Lello J. Mixed models: getting the best use of parasitological data. Trends Parasitol 2003; 19: 370-375.
39. Bolker BM, Brooks ME, Clark CJ, et al. Generalized linear mixed models: a practical guide for ecology and evolution. Trends Ecol Evol 2009; 24: 127-135.
40. Pollitt LC, Reece SE, Mideo N, Nussey DH & Colegrave N. The problem of auto-correlation in parasitology. PLoS Pathog 2012; 8: e1002590.
41. Johnson JB & Omland KS. Model selection in ecology and evolution. Trends Ecol Evol 2004; 19: 101-108.
42. Klein J. The Natural History of the Major Histocompatibility Complex. New York, Wiley-Blackwell, 1986.
43. Figueroa F, Günther E & Klein J. MHC polymorphism pre-dating speciation. Nature 1988; 335: 265-267.
44. Hughes AL & Nei M. Pattern of nucleotide substitution at major histocompatibility complex class I loci reveals overdominant selection. Nature 1988; 335: 167-170.
45. Piertney SB & Oliver MK. The evolutionary ecology of the major histocompatibility complex. Heredity 2006; 96: 7-21.
46. Sommer S. The importance of immune gene variability (MHC) in evolutionary ecology and conservation. Front Zool 2005; 2: 16.
47. Paterson S, Wilson K & Pemberton JM. Major histocompatibility complex variation associated with juvenile survival and parasite resistance in a large unmanaged ungulate population (Ovis aries L.). Proc Natl Acad Sci USA 1998; 95: 3714-3719.
48. Jepson A, Banya W, Sisay-Joof F, et al. Quantification of the relative contribution of major histocompatibility complex (MHC) and non-MHC genes to human immune responses to foreign antigens. Infect Immun 1997; 65: 872-876.
49. Fumagalli M, Pozzoli U, Cagliani R, et al. Parasites represent a major selective force for interleukin genes and shape the genetic predisposition to autoimmune conditions. J Exp Med 2009; 206: 1395-1408.
50. Fumagalli M, Sironi M, Pozzoli U, et al. Signatures of environmental genetic adaptation pinpoint pathogens as the main selective pressure through human evolution. PLoS Genet 2011; 7: e1002355.
51. Acevedo-Whitehouse K & Cunningham AA. Is MHC enough for understanding wildlife immunogenetics? Trends Ecol Evol 2006; 21: 433-438.
52. Beutler B. Innate immunity: an overview. Mol Immunol 2004; 40: 845-859.
53. Netea MG, Wijmenga C & O'Neill LAJ. Genetic variation in Toll-like receptors and disease susceptibility. Nat Immunol 2012; 13: 535-542.
54. Schröder NWJ & Schumann RR. Single nucleotide polymorphisms of Toll-like receptors and and susceptibility to infectious disease. Lancet Infect Dis 2005; 5: 156-164.
55. Tschirren B, Råberg L & Westerdahl H. Signatures of selection acting on the innate immunity gene Toll-like receptor 2 (TLR2) during the evolutionary history of rodents. J Evol Biol 2011; 24: 1232-1240.
56. Takeda K, Kaisho T & Akira S. Toll-like receptors. Annu Rev Immunol 2003; 21: 335-376.
57. Gautam JK, Ashish, Comeau LD, Krueger JK, Smith MF. Structural and functional evidence for the role of the TLR2 DD loop in TLR1/TLR2 heterodimerization and signaling. J Biol Chem 2006; 281: 30132-30142.
58. Graham AL, Cattadori IM, Lloyd-Smith JO, Ferrari MJ & Bjørnstad ON. Transmission consequences of coinfection: cytokines writ large? Trends Parasitol 2007; 23: 284-291.
59. Van Deventer SJ. Cytokine and cytokine receptor polymorphisms in infectious disease. Intensive Care Med 2000; 26(Suppl 1): S98-S102.
60. Ollier WER. Cytokine genes and disease susceptibility. Cytokine 2004; 28: 174-178.
61. Stüber F. Cytokine gene polymorphism and host susceptibility to infection. In Kotb M & Calandra T (eds): Cytokines and Chemokines in Infectious Diseases Handbook. Totowa, New Jersey, Humana Press, 2003: 23-30.
62. Schwensow N, Axtner J & Sommer S. Are associations of immune gene expression, body condition and parasite burden detectable in nature? A case study in an endemic rodent from the Brazilian Atlantic Forest. Infect Genet Evol 2011; 11: 23-30.
63. Guivier E, Galan M, Salvador AR, et al. Tnf-α expression and promoter sequences reflect the balance of tolerance/resistance to Puumala hantavirus infection in European bank vole populations. Infect Genet Evol 2010; 10: 1208-1217.
64. Jackson JA, Begon M, Birtles R, et al. The analysis of immunological profiles in wild animals: a case study on immunodynamics in the field vole, Microtus agrestis. Mol Ecol 2011; 20: 893-909.
65. Turner A, Begon M, Jackson J & Paterson S. Evidence for selection at cytokine loci in a natural population of field voles (Microtus agrestis). Mol Ecol 2012; 21: 1632-1646.
66. Cavanagh RD, Lambin X, Ergon T, et al. Disease dynamics in cyclic populations of field voles (Microtus agrestis): cowpox virus and vole tuberculosis (Mycobacterium microti). Proc Biol Sci 2004; 271: 859-867.
67. Smith A, Telfer S, Burthe S, Bennett M & Begon M. Trypanosomes, fleas and field voles: ecological dynamics of a host-vector-parasite interaction. Parasitology 2005; 131: 355.
68. Telfer S, Begon M, Bennett M, et al. Contrasting dynamics of Bartonella spp. in cyclic field vole populations: the impact of vector and host dynamics. Parasitology 2007; 134(Pt 3): 413-425.
69. Telfer S, Clough HE, Birtles LRJ, et al. Ecological differences and coexistence in a guild of microparasites: Bartonella in wild rodents. Ecology 2007; 88: 1841-1849.
70. Burthe S, Bennett M, Kipar A, et al. Tuberculosis (Mycobacterium microti) in wild field vole populations. Parasitology 2008; 135: 309-317.
71. Graham AL, Allen JE & Read AF. Evolutionary causes and consequences of immunopathology. Annu Rev Ecol Evol Syst 2005; 36: 373-397.
72. Graham AL, Hayward AD, Watt KA, Pilkington JG, Pemberton JM & Nussey DH. Fitness correlates of heritable variation in antibody responsiveness in a wild mammal. Science 2010; 330: 662-665.
73. Miller CHT, Maher SG & Young HA. Clinical use of Interferon-gamma. Ann N Y Acad Sci 2009; 1182: 69-79.
74. Donnelly RP, Young HA & Rosenberg AS. An overview of cytokines and cytokine antagonists as therapeutic agents. Ann N Y Acad Sci 2009; 1182: 1-13.
75. Feldmann M. Many cytokines are very useful therapeutic targets in disease. J Clin Invest 2008; 118: 3533-3536.
76. Tayal V & Kalra BS. Cytokines and anti-cytokines as therapeutics - an update. Eur J Pharmacol 2008; 579: 1-12.
77. Ayres JS & Schneider DS. Tolerance of infections. Annu Rev Immunol 2012; 30: 271-294.
78. Medzhitov R, Schneider DS & Soares MP. Disease tolerance as a defense strategy. Science 2012; 335: 936-941.
79. Schafer JF. Tolerance to plant disease. Annu Rev Phytopathol 1971; 9: 235-252.
80. Kover PX & Schaal BA. Genetic variation for disease resistance and tolerance among Arabidopsis thaliana accessions. Proc Natl Acad Sci USA 2002; 99: 11270-11274.
81. Van Bers NEM, Van Oers K, Kerstens HHD, et al. Genome-wide SNP detection in the great tit Parus major using high throughput sequencing. Mol Ecol 2010; 19(Suppl 1): 89-99.
82. Vera JC, Wheat CW, Fescemyer HW, et al. Rapid transcriptome characterization for a nonmodel organism using 454 pyrosequencing. Mol Ecol 2008; 17: 1636-1647.
83. Ellegren H. Sequencing goes 454 and takes large-scale genomics into the wild. Mol Ecol 2008; 17: 1629-1631.